SGLT-2 Inhibitors Vigorously Increase in Anterio’s “Mind Share” Ranking in May

June 25, 2014
According to Anterio’s “Mind Share” ranking, which surveys and indexes the mind share of ethical drugs (drugs that left an impression on doctors due to the quality and volume of detailing) by promotional channel, Astellas Pharma’s sodium-glucose co-transporter-2 (SGLT-2) inhibitor...read more